Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Brainstem evoked potentials in diagnosis of infantile hypoacusis].
Gómez Estancona N, Tena AG, Muñiz L, Urruticoechea L, Aristimuno D, Unanue J. Gómez Estancona N, et al. Among authors: urruticoechea l. An Otorrinolaringol Ibero Am. 1995;22(3):229-38. An Otorrinolaringol Ibero Am. 1995. PMID: 7625596 Spanish.
[Tonsillectomies and adenoidectomies with less than six hour admittance].
Gómez Estancona N, Tena AG, Urruticoechea L, Muñiz L, Unanue JM, Aristimuño D, Sopelana B, Basterra M, Garran B, Fernández Urarte A, et al. Gómez Estancona N, et al. Among authors: urruticoechea l. An Otorrinolaringol Ibero Am. 1995;22(3):221-8. An Otorrinolaringol Ibero Am. 1995. PMID: 7625595 Spanish.
Solar recharging system for hearing aid cells.
Gòmez Estancona N, Tena AG, Torca J, Urruticoechea L, Muñiz L, Aristimuño D, Unanue JM, Torca J, Urruticoechea A. Gòmez Estancona N, et al. Among authors: urruticoechea l. J Laryngol Otol. 1994 Sep;108(9):768-9. doi: 10.1017/s0022215100128063. J Laryngol Otol. 1994. PMID: 7964140
A phase II trial of first-line sorafenib in patients with metastatic renal cell carcinoma unwilling to receive or with early intolerance to immunotherapy: SOGUG Study 06-01.
Bellmunt J, Maroto-Rey P, Trigo JM, Carles J, Guillem V, López-Martín JA, Antón-Torres A, Urruticoechea L. Bellmunt J, et al. Among authors: urruticoechea l. Clin Transl Oncol. 2010 Jul;12(7):503-8. doi: 10.1007/s12094-010-0544-2. Clin Transl Oncol. 2010. PMID: 20615828 Clinical Trial.
Sorafenib TARGET trial results in Spanish patients.
Bellmunt J, González-Larriba JL, Climent MA, López-Vivanco G, Urruticoechea L, Albanell J. Bellmunt J, et al. Among authors: urruticoechea l. Clin Transl Oncol. 2007 Oct;9(10):671-3. doi: 10.1007/s12094-007-0120-6. Clin Transl Oncol. 2007. PMID: 17974528 Clinical Trial.
Ifosfamide and irinotecan in solid tumors: a phase I dose-finding trial.
Moyano AJ, Seguí MA, Abad T, Urruticoechea L, García López JL, Nogué M, Dominguez MS, Balcells M, Dorado JF. Moyano AJ, et al. Among authors: urruticoechea l. Semin Oncol. 2000 Feb;27(1 Suppl 1):3-7. Semin Oncol. 2000. PMID: 10697037 Clinical Trial.